Krishna Instit Of Medical Sciences Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
2099.65 -32.50 (-1.52%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2085
Today’s High
2139.95
52 Week Low
1625.05
52 Week High
2357
2094.25 -39.30 (-1.84%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
2083
Today’s High
2137.8
52 Week Low
1720
52 Week High
2356.4
Key Metrics
- Market Cap (In Cr) 16680.59
- Beta -
- Div. Yield (%) 0
- P/B 9.12
- TTM P/E 53.13
- Peg Ratio 3.49
- Sector P/E 26.87
- D/E 0.74
- Open Price 2139.95
- Prev Close 2132.15
Krishna Instit Of Medical Sciences Analysis
Price Analysis
-
1 Week3.83%
-
3 Months4.4%
-
6 Month8.96%
-
YTD7.8%
-
1 Year19.36%
Risk Meter
- 24% Low risk
- 24% Moderate risk
- 24% Balanced Risk
- 24% High risk
- 24% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 3
- Buy
- 3
- 3
- 3
- 3
- Hold
- 0
- 0
- 0
- 1
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 8
- 8
- 8
- 7
Krishna Instit Of Medical Sciences News
Ashish Kacholia cashes in on this debut stock after strong listing
1 min read . 29 Jun 2021Krishna Instit Of Medical Sciences Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2498.14
- Selling/ General/ Admin Expenses Total
- 422.37
- Depreciation/ Amortization
- 146.55
- Other Operating Expenses Total
- 905.06
- Total Operating Expense
- 2004.27
- Operating Income
- 493.88
- Net Income Before Taxes
- 459.64
- Net Income
- 310.15
- Diluted Normalized EPS
- 38.75
- Period
- 2024
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 181.9
- Period
- 2024
- Cashfrom Operating Activities
- 521.08
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023
- Total Revenue
- 2197.68
- Selling/ General/ Admin Expenses Total
- 564.4
- Depreciation/ Amortization
- 129.26
- Other Operating Expenses Total
- 6.04
- Total Operating Expense
- 1706.63
- Operating Income
- 491.05
- Net Income Before Taxes
- 484.91
- Net Income
- 336.32
- Diluted Normalized EPS
- 40.57
- Period
- 2023
- Total Assets
- 2941.3
- Total Liabilities
- 1271.76
- Total Equity
- 1669.54
- Tangible Book Valueper Share Common Eq
- 160.42
- Period
- 2023
- Cashfrom Operating Activities
- 563.23
- Cashfrom Investing Activities
- -615.6
- Cashfrom Financing Activities
- 88.34
- Net Changein Cash
- 35.98
- Period
- 2022
- Total Revenue
- 1650.82
- Selling/ General/ Admin Expenses Total
- 421.91
- Depreciation/ Amortization
- 72.67
- Other Operating Expenses Total
- 5.33
- Total Operating Expense
- 1203.68
- Operating Income
- 447.14
- Net Income Before Taxes
- 456.85
- Net Income
- 332.68
- Diluted Normalized EPS
- 42.14
- Period
- 2022
- Total Assets
- 1907.35
- Total Liabilities
- 520.04
- Total Equity
- 1387.31
- Tangible Book Valueper Share Common Eq
- 158.79
- Period
- 2022
- Cashfrom Operating Activities
- 324.02
- Cashfrom Investing Activities
- -411.52
- Cashfrom Financing Activities
- 61
- Net Changein Cash
- -26.49
- Period
- 2021
- Total Revenue
- 1329.94
- Selling/ General/ Admin Expenses Total
- 357.9
- Depreciation/ Amortization
- 69.54
- Other Operating Expenses Total
- 4.06
- Total Operating Expense
- 1026.8
- Operating Income
- 303.14
- Net Income Before Taxes
- 279.02
- Net Income
- 201.22
- Diluted Normalized EPS
- 25.24
- Period
- 2021
- Total Assets
- 1436.15
- Total Liabilities
- 572.42
- Total Equity
- 863.73
- Tangible Book Valueper Share Common Eq
- 94.24
- Period
- 2021
- Cashfrom Operating Activities
- 355.97
- Cashfrom Investing Activities
- -354.18
- Cashfrom Financing Activities
- 9.82
- Net Changein Cash
- 11.62
- Period
- 2020
- Total Revenue
- 1122.64
- Selling/ General/ Admin Expenses Total
- 329.18
- Depreciation/ Amortization
- 70.61
- Other Operating Expenses Total
- 3.43
- Total Operating Expense
- 946.22
- Operating Income
- 176.42
- Net Income Before Taxes
- 140.53
- Net Income
- 119.18
- Diluted Normalized EPS
- 15.02
- Period
- 2020
- Total Assets
- 1195.89
- Total Liabilities
- 597.76
- Total Equity
- 598.12
- Tangible Book Valueper Share Common Eq
- 60.87
- Period
- 2020
- Cashfrom Operating Activities
- 201.5
- Cashfrom Investing Activities
- -124.71
- Cashfrom Financing Activities
- -44.34
- Net Changein Cash
- 32.45
- Period
- 2019
- Total Revenue
- 918
- Selling/ General/ Admin Expenses Total
- 298.76
- Depreciation/ Amortization
- 56.46
- Other Operating Expenses Total
- 3.05
- Total Operating Expense
- 805.44
- Operating Income
- 112.56
- Net Income Before Taxes
- -15.38
- Net Income
- -47.77
- Diluted Normalized EPS
- -5.96
- Period
- 2019
- Total Assets
- 1119.71
- Total Liabilities
- 579.05
- Total Equity
- 540.66
- Tangible Book Valueper Share Common Eq
- 54.86
- Period
- 2019
- Cashfrom Operating Activities
- 133.9
- Cashfrom Investing Activities
- -109.76
- Cashfrom Financing Activities
- -27.04
- Net Changein Cash
- -2.9
- Period
- 2018
- Total Revenue
- 663.67
- Selling/ General/ Admin Expenses Total
- 200.85
- Depreciation/ Amortization
- 40.07
- Other Operating Expenses Total
- 2.21
- Total Operating Expense
- 534.69
- Operating Income
- 128.98
- Net Income Before Taxes
- -20.45
- Net Income
- -47.36
- Diluted Normalized EPS
- -8.58
- Period
- 2018
- Total Assets
- 958.01
- Total Liabilities
- 1116.45
- Total Equity
- -158.44
- Tangible Book Valueper Share Common Eq
- -25.47
- Period
- 2018
- Cashfrom Operating Activities
- 105.77
- Cashfrom Investing Activities
- -63.73
- Cashfrom Financing Activities
- -39.36
- Net Changein Cash
- 2.68
- Period
- 2024-03-31
- Total Revenue
- 633.8
- Selling/ General/ Admin Expenses Total
- 108.54
- Depreciation/ Amortization
- 46.3
- Other Operating Expenses Total
- 231.97
- Total Operating Expense
- 521.13
- Operating Income
- 112.67
- Net Income Before Taxes
- 100.12
- Net Income
- 65.6
- Diluted Normalized EPS
- 8.18
- Period
- 2024-03-31
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 181.9
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 521.08
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023-12-31
- Total Revenue
- 605.84
- Selling/ General/ Admin Expenses Total
- 104.25
- Depreciation/ Amortization
- 35.38
- Other Operating Expenses Total
- 228.9
- Total Operating Expense
- 494.09
- Operating Income
- 111.74
- Net Income Before Taxes
- 102.45
- Net Income
- 71.84
- Diluted Normalized EPS
- 8.98
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 652.48
- Selling/ General/ Admin Expenses Total
- 105.67
- Depreciation/ Amortization
- 32.61
- Other Operating Expenses Total
- 229.13
- Total Operating Expense
- 507.82
- Operating Income
- 144.67
- Net Income Before Taxes
- 138.62
- Net Income
- 92.02
- Diluted Normalized EPS
- 11.5
- Period
- 2023-09-30
- Total Assets
- 3418.94
- Total Liabilities
- 1605.73
- Total Equity
- 1813.22
- Tangible Book Valueper Share Common Eq
- 179.01
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 270.88
- Cashfrom Investing Activities
- -369.59
- Cashfrom Financing Activities
- 74.99
- Net Changein Cash
- -23.72
- Period
- 2023-06-30
- Total Revenue
- 606.03
- Selling/ General/ Admin Expenses Total
- 103.91
- Depreciation/ Amortization
- 32.26
- Other Operating Expenses Total
- 215.06
- Total Operating Expense
- 481.23
- Operating Income
- 124.8
- Net Income Before Taxes
- 118.58
- Net Income
- 80.82
- Diluted Normalized EPS
- 10.1
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 575.93
- Selling/ General/ Admin Expenses Total
- 91.77
- Depreciation/ Amortization
- 35.43
- Other Operating Expenses Total
- 198.84
- Total Operating Expense
- 448.13
- Operating Income
- 127.8
- Net Income Before Taxes
- 127.27
- Net Income
- 93.27
- Diluted Normalized EPS
- 11.66
- Period
- 2023-03-31
- Total Assets
- 2941.3
- Total Liabilities
- 1271.76
- Total Equity
- 1669.54
- Tangible Book Valueper Share Common Eq
- 160.42
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 563.23
- Cashfrom Investing Activities
- -615.6
- Cashfrom Financing Activities
- 88.34
- Net Changein Cash
- 35.98
- Period
- 2022-12-31
- Total Revenue
- 562.16
- Selling/ General/ Admin Expenses Total
- 87.2
- Depreciation/ Amortization
- 33.29
- Other Operating Expenses Total
- 200.28
- Total Operating Expense
- 444.27
- Operating Income
- 117.89
- Net Income Before Taxes
- 112.82
- Net Income
- 75.98
- Diluted Normalized EPS
- 9.49
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Krishna Instit Of Medical Sciences Technical
Moving Average
SMA
- 5 Day2099.08
- 10 Day2080.6
- 20 Day1985.88
- 50 Day1978.18
- 100 Day2047
- 300 Day2002.68
Krishna Instit Of Medical Sciences Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Dr. Lal Pathlabs
- 2783.65
- -42.05
- -1.49
- 2889.45
- 1943.2
- 23163.61
- Aster DM Healthcare
- 348.1
- -2
- -0.57
- 430.11
- 213.44
- 17327.48
- Krishna Instit Of Medical Sciences
- 2099.65
- -32.5
- -1.52
- 2357
- 1625.05
- 16803.08
- Rainbow Childrens Medicare
- 1257.15
- 1.4
- 0.11
- 1649
- 880.05
- 12760.32
- Metropolis Healthcare
- 2012.2
- -42.6
- -2.07
- 2067.7
- 1296
- 10308.26
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Dr. Lal Pathlabs
- 63.91
- 12.37
- 21.32
- 15.99
- Aster DM Healthcare
- 140.9
- 3.79
- 6.24
- 4.26
- Krishna Instit Of Medical Sciences
- 54.27
- 9.2
- 22.79
- 15.53
- Rainbow Childrens Medicare
- 58.93
- 10.16
- 19.88
- 13.8
- Metropolis Healthcare
- 77.89
- 9.05
- 20.59
- 14.66
Krishna Instit Of Medical Sciences Shareholding
Shareholding Pattern
*Promoter pledging: 6.25%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-Jun-24
- Stock Split
- 16-May-24
- Audited Results
- 03-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 18-May-23
- Audited Results
- 09-Feb-23
- Quarterly Results
- 04-Jan-23
- Others
- 11-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 01-Jan-24
- 30-Nov-23
- POM
- 30-Aug-23
- 18-May-23
- AGM
- 14-Feb-23
- 13-Jan-23
- POM
- 11-Aug-22
- 19-May-22
- AGM
- 13-Jun-22
- 12-May-22
- POM
- Ex-Splits
- Old FV
- New FV
- Description
- -
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.